A Granulomatous Drug Eruption Induced by Entecavir
Annals of Dermatology
;
: 493-495, 2013.
Article
Dans Anglais
| WPRIM
| ID: wpr-123640
ABSTRACT
Entecavir (Baraclude(R), Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache, abdominal pain, cough, pyrexia, fatigue, and diarrhea. Although quite a few randomized double-blind studies including ones investigating adverse events along with these general symptoms have been reported, few cases of cutaneous adverse events have been described in detail. We demonstrate a case of granulomatous drug eruption as a cutaneous adverse event induced by entecavir.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Infections de l'appareil respiratoire
/
Douleur abdominale
/
Méthode en double aveugle
/
Toxidermies
/
Hépatite B chronique
/
Toux
/
Diarrhée
/
Alanine transaminase
/
Fatigue
/
Fièvre
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Annals of Dermatology
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS